Videos
Morning
Session before break (2 hrs 45 mins - Real
Video)
Morning
Session after break (42 mins- Real Video)
Afternoon
Session before break (1 hr 50 mins - Real
Video)
Afternoon
Session after break (1 hr 10 mins - Real
Video)
Caption
Text
AGENDA
8:30 a.m. - 8:40 a.m. Opening Remarks
Elias Zerhouni, M.D., Director, NIH
Opening
Remarks (Real Video)
Dr
Zerhouni's Introductory - RAC Safety Symposium - Presentation (PDF)
8:40 a.m. - 9:00 a.m. Welcome and Introduction
Moderators: Neal DeLuca, Ph.D., University of Pittsburgh - Presentation (PDF)
Kathryn Holmes, Ph.D., University of Colorado - Presentation (PDF)
Welcome
and Introduction (Real Video)
9:00 a.m. - 9:15 a.m. Roundtable Introductions
Roundtable
Introductions (Real Video)
Session I: Recombinant Influenza Virus
Research
9:15 a.m. - 9:45 a.m. Reverse Genetics Techniques
to Generate Recombinant Viruses
Yoshihiro Kawaoka, D.V.M., Ph.D., University
of Wisconsin, Madison
Recombinant
Influenza Virus Research (Real Video)
Reverse
Genetics Techniques to Generate Recombinant Viruses (PDF)
9:45 a.m. - 10:15 a.m.Characterization of the
1918 Influenza Virus
Adolfo García-Sastre, Ph.D., Mount Sinai School
of Medicine
Characterization
of the 1918 Influenza Virus (Real Video)
Characterization
of the 1918 Influenza Virus (PDF)
10:15 a.m. - 10:45 a.m. Highly Pathogenic Avian
Influenza Virus Research
Robert Webster, Ph.D., St. Jude Children's
Research Hospital
Highly
Pathogenic Avian Influenza Virus Research (Real Video)
Highly
Pathogenic Avian Influenza Virus Research (PDF)
10:45 a.m. - 11:15 a.m. Vaccine Applications
Kanta Subbarao, M.D., M.P.H., National Institute
of Allergy and Infectious Diseases, NIH
Vaccine
Applications (Real Video)
Vaccine
Applications (PDF)
11:15 a.m. - 11:30 a.m. Break
Session II: SARS - Corona Virus
11:30 a.m. - 12:00 noon
Recombinant SARS-CoV
Research
Ralph Baric, Ph.D., University of North Carolina,
Chapel Hill
Recombinant
SARS-CoV Research (Real Video)
Recombinant
SARS-CoV Research (PDF)
12:00 noon - 1:00 p.m. Lunch
Session III: Lessons from Research with Infectious
Viruses
1:00 p.m. - 1:15 p.m. Early Research with HIV
Larry Arthur, Ph.D., National Cancer Institute
at Frederick, NIH
Early
Research with HIV (Real Video)
Early
Research with HIV (PDF)
1:15 p.m. - 1:30 p.m. Newcastle Disease Virus
Research
Siba Samal, Ph.D., M.V.Sc., University of Maryland,
College Park
Newcastle
Disease Virus Research (Real Video)
Newcastle
Disease Virus (PDF)
Session
IV: Guidance Provided by the NIH Guidelines
for Research Involving Recombinant DNA Molecules
and Biosafety in Microbiological and Biomedical
Laboratories (4th edition) and U.S. Department
of Agriculture (USDA) Regulations
1:30 p.m. - 2:00 p.m. Risk Assessment and Containment
Emmett Barkley, Ph.D., Howard Hughes Medical
Institute
Risk
Assessment and Containment (Real Video)
Risk
Assessment and Containment (PDF)
2:00 p.m. - 2:15 p.m. Update on the Revision
to the Influenza Section of Biosafety in Microbiological
and Biomedical Laboratories (4th edition)
Deborah Wilson, Dr.P.H., CBSP, Office of Research
Services, NIH
Update
on the Revision to the Influenza (Real
Video)
Impact
on Influenza Research in the United States (PDF)
2:15 p.m. - 2:30 p.m. USDA Guidance
Lee Ann Thomas, D.V.M., M.S., Animal and Plant
Health Inspection Service, USDA
USDA
Guidance (Real Video)
2:30 p.m. - 3:00 p.m. Public Questions and
Comments
3:00 p.m. - 3:15 p.m. Break
3:15 p.m. - 5:00 p.m.
Discussion of
Points to Consider to Assist Institutional Biosafety
Committee Reviews
Discussion
of Points to Concider (Real Video)
5:00 p.m. Adjournment
|
